Graves' Orbitopathy

Showing 1 - 3 of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)

Completed
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Placebo
  • Beverly Hills, California
  • +13 more
Jan 31, 2022

Graves' Orbitopathy Trial in Pisa (Atorvastatin 20mg, Placebo)

Not yet recruiting
  • Graves' Orbitopathy
  • Atorvastatin 20mg
  • Placebo
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
Sep 8, 2021

Thyroid Eye Disease, Graves' Orbitopathy Trial in United States (Teprotumumab)

Approved for marketing
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Beverly Hills, California
  • +7 more
Mar 13, 2020